TR199900186T2 - H�cre proliferasyonunun engellenmesine y�nelik ikameli/katk�l� bisindolilmaleimidler - Google Patents

H�cre proliferasyonunun engellenmesine y�nelik ikameli/katk�l� bisindolilmaleimidler

Info

Publication number
TR199900186T2
TR199900186T2 TR1999/00186T TR9900186T TR199900186T2 TR 199900186 T2 TR199900186 T2 TR 199900186T2 TR 1999/00186 T TR1999/00186 T TR 1999/00186T TR 9900186 T TR9900186 T TR 9900186T TR 199900186 T2 TR199900186 T2 TR 199900186T2
Authority
TR
Turkey
Prior art keywords
inhibition
cell proliferation
formula
bisindolylmaleimides
substituted
Prior art date
Application number
TR1999/00186T
Other languages
English (en)
Turkish (tr)
Inventor
Hooda Dhingra Urvashi
Mary Huryn Donna
Dalton Keith Dennis
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of TR199900186T2 publication Critical patent/TR199900186T2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
TR1999/00186T 1996-07-29 1997-07-19 H�cre proliferasyonunun engellenmesine y�nelik ikameli/katk�l� bisindolilmaleimidler TR199900186T2 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2207896P 1996-07-29 1996-07-29
US4849697P 1997-06-03 1997-06-03

Publications (1)

Publication Number Publication Date
TR199900186T2 true TR199900186T2 (xx) 1999-03-22

Family

ID=26695475

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/00186T TR199900186T2 (xx) 1996-07-29 1997-07-19 H�cre proliferasyonunun engellenmesine y�nelik ikameli/katk�l� bisindolilmaleimidler

Country Status (20)

Country Link
US (1) US6228877B1 (enExample)
EP (1) EP0915870B1 (enExample)
JP (1) JP2000516588A (enExample)
KR (1) KR20000029640A (enExample)
CN (1) CN1077571C (enExample)
AR (1) AR007969A1 (enExample)
AT (1) ATE224889T1 (enExample)
AU (1) AU740011B2 (enExample)
BR (1) BR9711607A (enExample)
CA (1) CA2262089A1 (enExample)
CO (1) CO4900054A1 (enExample)
DE (1) DE69715870T2 (enExample)
DK (1) DK0915870T3 (enExample)
ES (1) ES2183163T3 (enExample)
HR (1) HRP970415A2 (enExample)
MA (1) MA24354A1 (enExample)
PE (1) PE91598A1 (enExample)
PT (1) PT915870E (enExample)
TR (1) TR199900186T2 (enExample)
WO (1) WO1998004551A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2208612C2 (ru) * 1998-03-17 2003-07-20 Ф.Хоффманн-Ля Рош Аг Замещенные бисиндолималеимиды, предназначенные для ингибирования пролиферации клеток
US6350786B1 (en) 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
US6559164B1 (en) 1999-10-12 2003-05-06 Hoffmann-La Roche Inc. Substituted pyrroles suitable for continuous infusion
CN1155595C (zh) * 1999-10-12 2004-06-30 霍夫曼-拉罗奇有限公司 作为用于治疗癌症的抗增殖剂的取代的吡咯类化合物
US6313143B1 (en) * 1999-12-16 2001-11-06 Hoffmann-La Roche Inc. Substituted pyrroles
US6281356B1 (en) * 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
US6326501B1 (en) * 2000-04-19 2001-12-04 Hoffmann-La Roche Inc. Methylation of indole compounds using dimethyl carbonate
US7129250B2 (en) 2000-05-19 2006-10-31 Aegera Therapeutics Inc. Neuroprotective and anti-proliferative compounds
CA2308994A1 (en) * 2000-05-19 2001-11-19 Aegera Therapeutics Inc. Neuroprotective compounds
TW201041580A (en) 2001-09-27 2010-12-01 Alcon Inc Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
EP1441772A2 (en) * 2001-10-29 2004-08-04 Nektar Therapeutics Al, Corporation Polymer conjugates of protein kinase c inhibitors
CA2393720C (en) * 2002-07-12 2010-09-14 Eli Lilly And Company Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
WO2006086484A1 (en) 2005-02-09 2006-08-17 Arqule, Inc. Meleimide derivatives, pharmaceutical compositions and methods for treatment of cancer
MX2009006533A (es) * 2006-12-19 2009-06-26 Novartis Ag Derivados de indolil-maleimida como inhibidores de cinasa.
EP2170870B1 (en) * 2007-06-22 2014-03-05 ArQule, Inc. Pyrrolidinone, pyrrolidine-2, 5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer
WO2009002808A2 (en) 2007-06-22 2008-12-31 Arqule, Inc. Quinazolinone compounds and methods of use thereof
JP5490688B2 (ja) 2007-06-22 2014-05-14 アークル インコーポレイテッド 癌の治療のためのインドリルピロリジン
GB201111427D0 (en) * 2011-07-05 2011-08-17 Amakem Nv Novel bisindolylmaleimides, pan-pkc inhibitors
EP3741375A1 (en) 2014-07-17 2020-11-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for treating neuromuscular junction-related diseases
WO2016207366A1 (en) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections
CN109535158B (zh) * 2016-04-26 2021-04-23 浙江工业大学 一种双芳基马来酰亚胺类化合物及其药学上可接受的盐及其制备方法和应用
CN107973785B (zh) * 2017-11-27 2019-12-31 浙江工业大学上虞研究院有限公司 一种用于检测银离子的荧光探针及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227850A (en) * 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
PT93947B (pt) * 1989-05-05 1996-11-29 Goedecke Ag Processo para a preparacao de novos derivados de maleinimidas e de composicoes farmaceuticas que os contem
US5380746A (en) 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
JPH0539289A (ja) 1991-02-15 1993-02-19 Masahiro Irie 無水マレイン酸誘導体およびその製造方法
EP0630241A1 (en) 1992-03-20 1994-12-28 The Wellcome Foundation Limited Indole derivatives with antiviral activity
DE4217964A1 (de) 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung

Also Published As

Publication number Publication date
CO4900054A1 (es) 2000-03-27
CA2262089A1 (en) 1998-02-05
MA24354A1 (fr) 1998-07-01
EP0915870A1 (en) 1999-05-19
WO1998004551A1 (en) 1998-02-05
PE91598A1 (es) 1998-12-24
CN1077571C (zh) 2002-01-09
DK0915870T3 (da) 2003-02-03
HRP970415A2 (en) 1998-08-31
US6228877B1 (en) 2001-05-08
JP2000516588A (ja) 2000-12-12
KR20000029640A (ko) 2000-05-25
ATE224889T1 (de) 2002-10-15
BR9711607A (pt) 1999-08-24
ES2183163T3 (es) 2003-03-16
AU740011B2 (en) 2001-10-25
AR007969A1 (es) 1999-11-24
PT915870E (pt) 2003-01-31
DE69715870D1 (de) 2002-10-31
DE69715870T2 (de) 2003-06-18
AU4296397A (en) 1998-02-20
CN1226248A (zh) 1999-08-18
EP0915870B1 (en) 2002-09-25

Similar Documents

Publication Publication Date Title
TR199900186T2 (xx) H�cre proliferasyonunun engellenmesine y�nelik ikameli/katk�l� bisindolilmaleimidler
ATE250576T1 (de) Substituierte pyrrolylverbindungen zur behandlung von entzündungen
AR038431A2 (es) Derivados 2-desoxo-15-alquilo de marcfortina
NO984718D0 (no) Irreversible inhibitorer for tyrosin-kinaser
IL132107A0 (en) Substituted phenyl derivatives their preparation and use
MX9702658A (es) Derivados novedosos de acido carboxilico, su preparacion y uso.
TR199900157T2 (xx) H�cre proliferasyon inhibisyonu i�in ikame edilmi� bisindolilmaleimidleri.
IL119207A0 (en) Treatment of tinnitus using neuroprotective agents
CY2431B1 (en) Novel phenanthridines substituted in the 6 position.
HRP930239A2 (en) Anti-inflamatory 4-aminophenol derivatives
TR199802060T2 (xx) Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
YU55200A (sh) Supstituisani bisindolmaleimidi za inhibiranje ćelijske proliferacije
DK1000034T3 (da) Substituerede 6-alkylphenanthridiner
TW287103B (enExample)
MY132057A (en) Quinoxalinones, a process for their preparation and their use
GB2324528B (en) Cytostatic hydroxamic acid derivatives
TR199900153T2 (xx) H�cre �o�almas�n� �nlemek i�in ikame edilmi� bisindolilmaleimitler.
TR199700921T1 (xx) �nsanlarda g�r�len herpes-vir�s-8'in tedavisinde pensiklovir'in kullan�lmas�.
TR199701011A2 (xx) 1-karba-(detia)-sefalosforin t�revleri.
CY2582B2 (en) New imidazopyridines and oxazolopyridines